Orange Book product · Brand (NDA)
ARICEPT
DONEPEZIL HYDROCHLORIDE
At a glance
Jul 23, 2010
Approved
Brand (NDA)
Application
AB
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 23, 2010
16 yr 2 mo ago
Today
Patent 8481565 expires
Listed drug product patent expiration.
Oct 04, 2026
in 4 mo
Pharmaceutical detail
Active ingredient
DONEPEZIL HYDROCHLORIDE
Strength
23MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 022568
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2022ADLARITYBrand (NDA)
NDA 212304 · CORIUM
- 2004ARICEPTBrand (NDA)
NDA 021719 · EISAI INC
- 2004ARICEPT ODTBrand (NDA)
NDA 021720 · EISAI INC
- 1996ARICEPTBrand (NDA)
NDA 020690 · EISAI INC
- 2018DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 205269 · HISUN PHARM HANGZHOU
- 2017DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 204609 · CADILA PHARMS LTD
- 2017DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 202410 · HISUN PHARM HANGZHOU
- 2016DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 204831 · UNICHEM
- 2016DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 203656 · UNICHEM
- 2016DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 203419 · CHARTWELL RX
- 2016DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 203713 · DEXCEL
- 2016DONEPEZIL HYDROCHLORIDEGeneric (ANDA)
ANDA 203114 · OSMOTICA PHARM US
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8481565 | Oct 04, 2026 | in 4 mo | Product |

